AI was intended to save patients cost in health care. However, experts say it's costlier than expected because humans need to help monitor it.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 ...

Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...